GotoPER - Physicians' Education Resource
Back to Home|Learning Hub

30th Annual International Congress on Hematologic Malignancies®:
Focus on Leukemias, Lymphomas, and Myeloma - Learning Hub

Stay up to date with the latest advances in hematologic malignancies through the 30th Annual International Congress on Hematologic Malignancies® Learning Hub.

Designed for easy, on-demand access, the hub features expert-led presentations, slides, and videos covering key updates across AML, NDMM, CML, DLBCL, and more. Whether you attended the meeting or are catching up, this free resource offers a convenient way to revisit insights and apply the latest developments to your clinical practice—all in one place.

This activity is supported by educational grants from Ascentage Pharma Inc; AstraZeneca Pharmaceuticals; Autolus Therapeutics; Daiichi Sankyo, Inc; Janssen Scientific Affairs, LLC; Novartis Pharmaceuticals Corporation; PharmaEssentia; Rigel Pharmaceuticals, Inc; and Sanofi.

11 Modules
Apr 20, 2026 – Mar 1, 2027

Browse and take individual modules below, or enroll in the full path to track your overall progress.

Register to Track ProgressLogin

Main Conference

Module 1: Acute Lymphoblastic Leukemia
Module 1

Module 1: Acute Lymphoblastic Leukemia

Naval G. Daver, MD; Elias Jabbour, MD; Aaron C. Logan, MD, PhD, MPhil; Bijal Shah, MD, MS

View Module

Slide Downloads

Module 2: Acute Myeloid Leukemia
Module 2

Module 2: Acute Myeloid Leukemia

Naval G. Daver, MD; Amir Fathi, MD; Sanam Loghavi, MD; Gail J. Roboz, MD; Aditi Shastri, MD

View Module

Slide Downloads

Module 3: Chronic Lymphocytic Leukemia (CLL)
Module 3

Module 3: Chronic Lymphocytic Leukemia (CLL)

André H. Goy, MD; Lorenzo Falchi, MD; Nicole Lamanna, MD; Lori A. Leslie, MD

View Module

Slide Downloads

Module 4: Diffuse Large B-Cell Lymphoma (DLBCL)
Module 4

Module 4: Diffuse Large B-Cell Lymphoma (DLBCL)

André H. Goy, MD; Lorenzo Falchi, MD; Christopher Flowers, MD, MS, FASCO; Lori A. Leslie, MD

View Module

Slide Downloads

Module 5: Mantle Cell Lymphoma and Indolent Non-Hodgkin Lymphoma (iNHL)
Module 5

Module 5: Mantle Cell Lymphoma and Indolent Non-Hodgkin Lymphoma (iNHL)

André H. Goy, MD; Lorenzo Falchi, MD; Christopher Flowers, MD, MS, FASCO; Lori A. Leslie, MD; Clémentine Sarkozy, MD, PhD

View Module

Slide Downloads

Module 6: Multiple Myeloma (MM): First-Line MM
Module 6

Module 6: Multiple Myeloma (MM): First-Line MM

Ajai Chari, MD; María-Victoria Mateos, MD, PhD; Luciano J. Costa, MD, PhD; C. Ola Landgren, MD, PhD; Suzanne Lentzsch, MD, PhD; Mohamad Mohty, MD, PhD; Krina Patel, MD, MSc

View Module

Slide Downloads

Module 7: Multiple Myeloma (MM): Relapsed/Refractory Disease
Module 7

Module 7: Multiple Myeloma (MM): Relapsed/Refractory Disease

Ajai Chari, MD; María-Victoria Mateos, MD, PhD; Luciano J. Costa, MD, PhD; C. Ola Landgren, MD, PhD; Suzanne Lentzsch, MD, PhD; Mohamad Mohty, MD, PhD

View Module

Slide Downloads

Module 8: Myelodysplastic Syndromes (MDS)
Module 8

Module 8: Myelodysplastic Syndromes (MDS)

Naval G. Daver, MD; Uma M. Borate, MBBS, MS; Guillermo Garcia-Manero, MD; Rami S. Komrokji, MD

View Module

Slide Downloads

Module 9: Emerging Strategies in Myeloproliferative Neoplasms
Module 9

Module 9: Emerging Strategies in Myeloproliferative Neoplasms

Naval G. Daver, MD; Gabriela Hobbs, MD; Hagop M. Kantarjian, MD; Naveen Pemmaraju, MD

View Module

Slide Downloads